NYSE:TARO

Taro Pharmaceutical Industries

Stock

42.98 +0.01%

0.01

USD last updated 22/08 01:43:23

Last Close

42.97

21/06 19:59

Market Cap

1.62B

Beta: 0.70

Volume Today

147.06K

Avg: 16.05K

PE Ratio

34.88

PFCF: 18.53

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Mar '15	Mar '16	Mar '17	Mar '18	Mar '19	Mar '20	Mar '21	Mar '22	Mar '23	Mar '24
revenue	862.94M -	950.75M 10.18%	879.39M 7.51%	661.91M 24.73%	669.89M 1.21%	644.77M 3.75%	548.97M 14.86%	561.35M 2.25%	572.95M 2.07%	629.18M 9.81%
cost of revenue	186.36M -	171.78M 7.82%	208.14M 21.16%	198.41M 4.68%	224.17M 12.99%	245.04M 9.31%	252.31M 2.97%	268.23M 6.31%	304.63M 13.57%	324.20M 6.43%
gross profit	676.59M -	778.97M 15.13%	671.25M 13.83%	463.51M 30.95%	445.72M 3.84%	399.73M 10.32%	296.66M 25.78%	293.12M 1.19%	268.32M 8.46%	304.98M 13.66%
selling and marketing expenses						36.66M -		56.62M -	113.28M 100.07%
general and administrative expenses						56.76M -		57.06M -	85.09M 49.12%
selling general and administrative expenses	87.64M -	92.36M 5.39%	85.66M 7.26%	88.20M 2.97%	89.97M 2.01%	93.41M 3.83%	91.36M 2.20%	113.68M 24.43%	198.37M 74.50%	218.94M 10.37%
research and development expenses	65.51M -	71.16M 8.62%	70.64M 0.73%	70.42M 0.32%	63.24M 10.20%	59.78M 5.47%	60.15M 0.63%	54.54M 9.33%	52.24M 4.21%	64.54M 23.53%
other expenses	2.74M -	2.68M 2.12%	11.21M 318.32%	1.89M 83.15%	1.81M 4.18%	3.02M 66.74%	2.89M 4.17%	4.23M 46.13%	2.46M 41.74%	64.54M 2,521.28%
cost and expenses	339.51M -	335.31M 1.24%	364.44M 8.69%	357.02M 2.04%	377.38M 5.70%	398.23M 5.53%	403.82M 1.40%	436.44M 8.08%	555.24M 27.22%	607.67M 9.44%
operating expenses	153.15M -	163.53M 6.77%	156.30M 4.42%	158.61M 1.48%	153.21M 3.41%	153.19M 0.01%	151.51M 1.10%	168.22M 11.03%	250.61M 48.98%	283.47M 13.11%
interest expense	928K -	473K 49.03%	131K 72.30%	304K 132.06%	256K 15.79%	725K 183.20%	1.36M 88%	1.65M 21.28%	-17.69M 1,169.93%
ebitda	493.39M -	624.19M 26.51%	509.61M 18.36%	355.74M 30.19%	282.13M 20.69%	253.08M 10.29%	728.12M 187.70%	210.28M 71.12%	52.65M 74.96%	52.60M 0.10%
operating income	527.63M -	614.47M 16.46%	514.95M 16.20%	303.01M 41.16%	296.19M 2.25%	246.53M 16.77%	704.44M 185.74%	184.37M 73.83%	17.71M 90.39%	21.51M 21.42%
depreciation and amortization	15.80M -	14.85M 6.01%	14.83M 0.13%	16.50M 11.24%	18.60M 12.74%	6.55M 64.80%	23.68M 261.75%	25.91M 9.44%	34.94M 34.83%	31.09M 11.01%
total other income expenses net	48.57M -	8.78M 81.93%	31.38M 257.60%	-32.46M 203.44%	30.80M 194.88%	51.50M 67.22%	-1.10B 2,227.21%	-106.51M 90.28%	20.50M 119.25%	61.16M 198.36%
income before tax	581.68M -	636.82M 9.48%	560.80M 11.94%	292.37M 47.87%	356.85M 22.06%	298.04M 16.48%	-391.07M 231.22%	77.86M 119.91%	38.21M 50.92%	82.67M 116.33%
income tax expense	96.06M -	95.31M 0.78%	103.78M 8.88%	81.95M 21.03%	74.73M 8.81%	53.48M 28.43%	9.67M 81.93%	19.59M 102.67%	12.77M 34.83%	28.80M 125.57%
net income	484.26M -	540.93M 11.70%	456.36M 15.64%	211.15M 53.73%	281.78M 33.45%	244.24M 13.32%	-400.74M 264.08%	58.27M 114.54%	25.45M 56.33%	53.87M 111.70%
weighted average shs out	42.83M -	42.83M 0.00%	41.30M 3.57%	40.16M 2.77%	38.99M 2.90%	38.46M 1.36%	38.21M 0.65%	37.64M 1.49%	37.58M 0.15%	37.58M 0%
weighted average shs out dil	42.83M -	42.83M 0.00%	41.30M 3.57%	40.16M 2.77%	38.99M 2.90%	38.46M 1.36%	38.21M 0.65%	37.64M 1.49%	37.58M 0.15%	37.58M 0%
eps	11.31 -	12.62 11.58%	11.05 12.44%	5.26 52.40%	7.23 37.45%	6.35 12.17%	-10.49 265.20%	1.55 114.78%	0.68 56.13%	1.43 110.29%
epsdiluted	11.31 -	12.62 11.58%	11.05 12.44%	5.26 52.40%	7.23 37.45%	6.35 12.17%	-10.49 265.20%	1.55 114.78%	0.68 56.13%	1.43 110.29%

All numbers in USD (except ratios and percentages)